With the emergence of specific genomic biomarker testing for multiple tumor types, many health systems have adapted existing workflows to implement new testing practices to support the appropriate delivery of precision medicine.
Clinical implementation of effective biomarker testing practices is key to ensuring timely provider access to biomarker test results to help inform clinical decision-making throughout the patient journey.
Hear from Vamsidhar Velcheti, MD, Professor of Medicine at NYU, discuss the latest developments in NSCLC biomarker testing and clinical implementation, and gain insights from those who have successfully implemented innovative solutions for delivery of precision medicine in NSCLC.